ANCHIANO THERAPEUTICS LTD's ticker is ANCN and the CUSIP is 03280X102. A total of 1 filers reported holding ANCHIANO THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,000 | -31.9% | 11,173 | 0.0% | 0.00% | – |
| Q2 2023 | $14,692 | -17.3% | 11,173 | 0.0% | 0.00% | – |
| Q1 2023 | $17,765 | -50.3% | 11,173 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $35,754 | +27.7% | 11,173 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $28,000 | -31.7% | 11,173 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $41,000 | – | 11,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MEITAV INVESTMENT HOUSE LTD | 234,402 | $267,000 | 0.01% |
| PALISADE CAPITAL MANAGEMENT, LP | 369,640 | $421,000 | 0.01% |
| Virtu Financial LLC | 13,133 | $15,000 | 0.00% |
| Phoenix Holdings Ltd. | 26,087 | $28,000 | 0.00% |
| REGENTATLANTIC CAPITAL LLC | 25,000 | $29,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 2,350 | $3,000 | 0.00% |